课题基金 / 基金详情

Natural killer receptor-mediated regulation of dendritic cell functions in chronic hepatitis C

Natural killer receptor-mediated regulation of dendritic cell functions in chronic hepatitis C
自然杀伤受体介导的慢性丙型肝炎树突状细胞功能的调节
批准号:
16390207
负责人:
TAKEHARA Tetsuo
金额:
$5.38万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

TAKEHARA Tetsuo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Natural kilier (NK) cells are specialized lymphocytes that provide a first line of defense through their ability to kill pathogen-infected cells and transformed cells. The function of NK cells is regulated by a fine balance of inhibitory and activating signals, which are mediated by a diverse array of cell-surface receptors. We recently found that expression of the inhibitory receptor CD94/NKG2A is upregulated on NK cells in patients with chronic hapatitis C. HLA-E, a ligand for NKG2A, was expressed in all human hepatoma cell lines tested as well as non-transformed hepatocytes, but not in K562 cells, a classical NK-sensitive target. NK cells isolated from patients with chronic hepatitis C (HCV-NK) were less capable of killing hepatoma cells and of producing IFNγ in response to hepatoma cells than those from healthy donors, whereas there was no significant difference in NK responsiveness towards K562 cells. Of note is the finding that maturation and activation of monocyte-derived dendritic cells were negatively modulated in the presence of HCV-NK and hepatoma cells, which was restored by the addition of anti-NKG2A antibody during the coculture of HCV-NK and hepatoma cells. Research revealed that dendritic cells recognize danger signals from microorganisms by monitoring pathogen-associated molecular patterns via Toll-like receptors. Our findings have shed light on NK receptors as an important interface that transmits danger signals from abnormal cells to immune systems. Aberrant expression of CD94/NKG2A should have negative impact on innate resistance and subsequent adaptive immunity towards HCV-infected or transformed cells in chronic hepatitis C.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.4049/jimmunol.173.10.6072
发表时间: 2004-11-15
期刊: JOURNAL OF IMMUNOLOGY
影响因子: 4.4
作者: [Jinushi, M, Takehara, T, Hayashi, N]
通讯作者: Hayashi, N
DOI: 10.1053/j.gastro.2004.07.019
发表时间: 2004-10-01
期刊: GASTROENTEROLOGY
影响因子: 29.4
作者: [Takehara, T, Tatsumi, T, Hayashi, N]
通讯作者: Hayashi, N
Quick generation of fully mature dendritic cells from monocytes with OK432, low-doseprostanoid and interferon-α as potent immune enhancers.
使用 OK432、低剂量前列腺素和干扰素-α 作为有效的免疫增强剂,从单核细胞快速生成完全成熟的树突状细胞。
DOI: --
发表时间: 2006
期刊: Journal of Immunotherapy 29
影响因子: --
作者: [Sakakibara M, Takehara T, et al.]
通讯作者: et al.
DOI: 10.1016/j.jhep.2005.07.030
发表时间: 2006-02-01
期刊: JOURNAL OF HEPATOLOGY
影响因子: 25.7
作者: [Takehara, T, Suzuki, T, Hayashi, N]
通讯作者: Hayashi, N
Molecular mechanisms of acinar cell injury in acute pancreatitis
  • 批准号:
    24659364
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.41万
  • 财政年份:
    2012
  • 负责人:
    TAKEHARA Tetsuo
  • 依托单位:
Regulation of autophagy and its impact in the development and progression of hepatocellular cancer.
  • 批准号:
    23390197
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $12.15万
  • 财政年份:
    2011
  • 负责人:
    TAKEHARA Tetsuo
  • 依托单位:
Bcl-2 network and regulation of cell death in non-alcoholic steatohepatitis
  • 批准号:
    21659188
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.11万
  • 财政年份:
    2009
  • 负责人:
    TAKEHARA Tetsuo
  • 依托单位:
Molecular mechanism of the ectodomain shedding of the NKG2D ligand MHC class I-related chain A in hepatocellular carcinoma and its therapeutic implication
  • 批准号:
    20390208
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.65万
  • 财政年份:
    2008
  • 负责人:
    TAKEHARA Tetsuo
  • 依托单位:
国内基金
海外基金
中国北方人群肺癌患者Cancer/Testis抗原表达谱绘制表位鉴定及功能性抗原特异性CTL制备研究
  • 批准号:
    81673007
  • 项目类别:
    面上项目
  • 资助金额:
    54.0万元
  • 批准年份:
    2016
  • 负责人:
    金时
  • 依托单位: